Mesenchymal stem cell therapy shows promise for treating multiple sclerosis (MS), with improvements seen in disability, walking ability, vision, and auditory function, according to a recent review of published studies. The approach also seems to be well tolerated by people with MS, but more research is needed on its long-term safety and efficacy, researchers noted. […]
The post Mesenchymal stem cell therapy shows promise for MS: Review appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com